infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: We prescribe evening primrose produced by Barij, 1000 ?milligram oral tab, BD, from ?three ?days before ?hysterosalpangiography to start of ?process in intervention
Treatment - Drugs
Intervention group: We prescribe evening primrose produced by Barij, 1000 ?milligram oral tab, BD, from ?three ?days before ?hysterosalpangiography to start of ?process in intervention group.
Control group: We prescribe placebo 1000 ?milligram oral tab, BD, from ?three ?days before ?hysterosalpangiography in control group.
Sponsors
Vice chancellor for research, Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:infertility; 20 to 40 years; female; candidate for hysterosalpangiography???; ??hysterosalpingography should be done just by one researcher resident. Exclusion criteria: Severe dysmenorrhea; Pelvic infection; history of cervical ??stenosis; Sensitization to intervention drug; duration of hysterosalpingography greater ??than 45 minutes; Unstable hydrodynamic symptoms during ??hysterosalpingography; Vaginal delivery; Secondary infertility ?
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: during and after hysterosalpangiography and 4 hours after hysterosalpangiography. Method of measurement: Visual Analogue Scale.;Tube spasm. Timepoint: During hysterosalpangiography? ?? ?. Method of measurement: observation by hysterosalpangiography? ?? ?. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Marayam Shokrpour
Arak University of Medical Sciences
Outcome results
None listed